MHRA Drug Safety Update August 2022

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 1 August 2022) has been published and includes articles on:

  • Nebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and managed only by specialists
  • COVID-19 vaccines and medicines: updates for August 2022
  • Letters and medicine recalls sent to healthcare professionals in July 2022

To see the latest MHRA Drug Safety Updates in full, visit the website.